Assessing Pathology and How It Impacts Early HER2 Breast Cancer Treatment

(MedPage Today) -- In "Beyond Diagnosis: Early HER2-Positive Breast Cancer," Cleveland Clinic breast oncologist Megan Kruse, MD, and host John Mangels discuss how clinicians can navigate increasingly complex treatment decisions while helping patients...